Finalizing FY 22 appropriations requires resolution of budget and reconciliation issues
With House passage of an FY 22 Ag/FDA appropriations bill (+$257 billion in BA funding) and the Senate Appropriations Committee having passed a bill (+$200 million in BA funding), FDA is on track to receive a substantial budget increase. Still unresolved and essential is how we lock in a $200-250 million increase for the agency and how do we assure those monies arrive at (or soon after) the start of the new federal fiscal year on October 1.
Senate Committee approves FY 22 Agriculture/FDA Appropriations Bill; Alliance expresses support for Congressional funding of FDA;
Senate Committee approves FY 22 Agriculture/FDA Appropriations Bill.
The Alliance appreciates increased FDA funding.
Congressional schedule limited between now and the new fiscal year.
The interaction of budget, appropriations, and reconciliation.
ARPA-H still drawing attention.
No Friday Update on August 13.
Q&A explaining ARPA-H, the opportunities, challenges and prospects for passage
What is the reason for the sudden focus on creating ARPA-H?
House-passed Ag/FDA funding: $257M increase for FDA; Senate Appropriations may consider Ag/FDA next week; support for ARPA-H formalizes
House Passes Ag/FDA funding as part of minibus Bill, including the $257M increase for FDA.
Senate Appropriations may consider Ag/FDA funding next week.
ARPA-H: Still formative with FDA’s role to be determined, and public comment being solicited.
Follow-ups to the McMeekin and Shuren webinars.